Biogen Beats

Biogen (BIIB) reported Quarter December 2025 earnings of $1.99 per share on revenue of $2.3 billion. The consensus earnings estimate was $1.61 per share on revenue of $2.2 billion. The Earnings Whisper number was $1.98 per share. Revenue fell 7.1% compared to the same quarter a year ago.

Biogen Idec Inc, is a biopharmaceutical company. The Company discovers, develops, manufactures and markets therapies for neurological, autoimmune and hematologic disorders.